Patent details
300831
Product Name:
Humane normale immunoglobuline
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300831
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2364730
Status:
Withdrawn
Application number:
300831
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
Marketing Authorization Number:
EU/1/11/687/001-012
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/04/2011
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
22/09/2016
First Marketing Authorization date:
18/04/2011
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/09/2016
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
21/09/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
28/09/2016
Name:
CSL Behring AG
Address:
Wankdorfstrasse 10, 3000 BERN 22, Switzerland (CH)
Agent
Name:
ir. F.A. Geurts c.s.
From:
28/09/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
39/20
Publication date:
23/09/2020
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
39/16
Publication date:
28/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
22/09/2020
Outgoing Correspondence
Letter confirmation withdrawal
1
PDF
/5/1/9/1/9/0800091915/docs/300831_7_367777l193.pdf
21/09/2020
SPC Documents
Withdrawal SPC
1
PDF
/5/1/9/1/9/0800091915/docs/300831_1_supplprotectioncertificate20200921033205022.pdf
29/07/2020
Outgoing Correspondence
Letter to applicant
2
PDF
/5/1/9/1/9/0800091915/docs/300831_2_357077l173.pdf
29/09/2016
Outgoing Correspondence
Confirmation receipt request
1
PDF
/5/1/9/1/9/0800091915/docs/300831_8_87228l174.pdf
22/09/2016
SPC Documents
Accompanying letter SPC
1
PDF
/5/1/9/1/9/0800091915/docs/300831_0_supplprotectioncertificate20210406020424269.pdf
22/09/2016
SPC Documents
Annex SPC
1
PDF
/5/1/9/1/9/0800091915/docs/300831_3_supplprotectioncertificate20200420014748114.pdf
22/09/2016
Application Form
First filed application form
3
PDF
/5/1/9/1/9/0800091915/docs/300831_4_applicationform20160927045136157.pdf
22/09/2016
SPC Documents
Marketing Authorization SPC
4
PDF
/5/1/9/1/9/0800091915/docs/300831_5_supplprotectioncertificate20160927045136498.pdf
22/09/2016
SPC Documents
Summary of the characteristics of the product
9
PDF
/5/1/9/1/9/0800091915/docs/300831_6_supplprotectioncertificate20160927045136575.pdf